Approximately 5.1 million Israelis had been fully immunized against coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) by May 31, 2021. After early reports of myocarditis during adverse events monitoring, the Israeli Ministry of Health initiated active surveillance.
The incidence of myocarditis, although low, increased after the receipt of the BNT162b2 vaccine, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.
Health experts have been left baffled by a big rise in a common and potentially fatal type of heart attack in the west of Scotland.
During the summer there was a 25 per cent rise in the number of people rushed to the Golden Jubilee National Hospital in Clydebank with partially blocked arteries cutting blood supply to the heart.